ReviewCancers2026
Minimally Invasive Surgical Approaches to Colorectal Cancer: Learning Curve and Cost Considerations.
Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Minimally invasive surgical (MIS) techniques have fundamentally transformed the management of colorectal cancer. Since the early 1990s, the field has rapidly evolved, shifting from initial concerns about oncologic safety to the widespread adoption of both laparoscopic and robotic surgeries. Specifically, laparoscopic approaches to colorectal cancer resection are now widely adopted and supported by robust randomized controlled trial evidence demonstrating favorable perioperative outcomes with equivalent oncologic results compared to open surgery. Robotic-assisted platforms have gained increasing adoption; however, their incremental clinical and oncologic benefit over laparoscopy remains under active investigation. As these technologies have been implemented, significant challenges related to surgical proficiency and economic sustainability have emerged. MIS approaches, particularly laparoscopic colectomies and proctectomies, involve steep, multidimensional learning curves that require substantial case volumes to achieve technical mastery and consistent clinical outcomes. Simultaneously, the rising costs of robotic platforms raise important considerations regarding the financial sustainability of healthcare systems. While robotic surgery may reduce certain downstream costs through shorter hospital stays and fewer complications, its substantially higher upfront operative costs and uncertain cost-effectiveness relative to laparoscopy require careful consideration, and access remains a barrier, particularly for patients without private insurance. This narrative review describes the evolution of MIS in colorectal cancer treatment and examines the dual considerations of the surgical learning curve and hospital cost implications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.